Chia Ling Wang
Direttore/Membro del Consiglio presso UNITED BIOPHARMA INC
Posizioni attive di Chia Ling Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
UNITED BIOPHARMA INC | Direttore/Membro del Consiglio | 30/09/2014 | - |
Independent Dir/Board Member | 30/09/2014 | - | |
SHANGHAI BAOLONG AUTOMOTIVE CORPORATION | Direttore/Membro del Consiglio | 01/01/2014 | - |
The Hong Kong University of Science & Technology | Corporate Officer/Principal | - | - |
Storia della carriera di Chia Ling Wang
Precedenti posizioni note di Chia Ling Wang
Società | Posizione | Inizio | Fine |
---|---|---|---|
TELEVISION BROADCASTS LIMITED | Direttore/Membro del Consiglio | 01/04/2015 | 26/05/2021 |
Independent Dir/Board Member | 01/04/2015 | 26/05/2021 |
Formazione di Chia Ling Wang
Harvard University | Graduate Degree |
University of Wisconsin-Milwaukee | Graduate Degree |
National Taiwan University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Taiwan | 3 |
Stati Uniti | 3 |
Hong Kong | 3 |
Posizioni
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Graduate Degree | 2 |
Settori
Consumer Services | 6 |
Health Technology | 2 |
Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
TELEVISION BROADCASTS LIMITED | Consumer Services |
SHANGHAI BAOLONG AUTOMOTIVE CORPORATION | Producer Manufacturing |
Aziende private | 1 |
---|---|
United BioPharma, Inc.
United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Chia Ling Wang
- Esperienza